PSP
GSK icon

Principal Street Partners’s GSK GSK Stock Holding History

Principal Street Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
+3,996
New +$217K 0.04% 215
2025
Q3 		– Sell
-6,480
Closed -$249K – 314
2025
Q2 		$249K Buy
+6,480
New +$248K 0.02% 308

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Principal Street Partners's GSK Position: Q1 2026 in Review

Principal Street Partners opened a new position in GSK (GSK) in Q1 2026: 3,996 shares worth $221K. The stake represents 0.04% of the portfolio and ranks #215 among its holdings. This is a return to the name: Principal Street Partners previously reported a position in GSK as recently as Q2 2025.

Principal Street Partners first reported a position in GSK in Q2 2025 and has held it in 2 quarters since. The position peaked at $249K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Principal Street Partners held 3,996 shares of GSK worth $221K as of Q1 2026.
  • GSK was a new Principal Street Partners position in Q1 2026.
  • GSK made up 0.04% of Principal Street Partners's portfolio in Q1 2026, its #215 holding.
  • Principal Street Partners first reported a position in GSK in Q2 2025 and has held it in 2 quarters since.
  • Principal Street Partners's GSK position peaked at $249K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.